We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Lundbeck Research USA, Inc. and BioFocus Sign Compound Management Agreement

News   Jan 26, 2011

 
Lundbeck Research USA, Inc. and BioFocus Sign Compound Management Agreement
 
 
 

RELATED ARTICLES

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

Drug Suppresses Formation of Metastases

News

The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers have now discovered a substance that suppresses the formation of metastases.

READ MORE

Anti-Wolbachia Drug with Potential to Treat Onchocerciasis & Lymphatic Filariasis

News

Researchers have successfully optimized a hit from a whole cell screening of a 10000-compound library to deliver the first novel fully synthetic and rationally designed anti-Wolbachia drug, AWZ1066S, which could potentially be used to treat onchocerciasis and lymphatic filariasis (LF).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE